Citadel Advisors - ANIXA BIOSCIENCES INC ownership

ANIXA BIOSCIENCES INC's ticker is ANIX and the CUSIP is 03528H109. A total of 42 filers reported holding ANIXA BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ANIXA BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$196,118
+7.7%
59,975
+5.4%
0.00%
Q2 2023$182,055
+61.5%
56,892
+117.0%
0.00%
Q1 2023$112,720
-56.7%
26,214
-57.2%
0.00%
Q4 2022$260,551
+168.6%
61,306
+212.6%
0.00%
Q3 2022$97,000
-45.2%
19,610
-66.1%
0.00%
Q2 2022$177,000
-4.8%
57,794
-7.6%
0.00%
Q4 2021$186,000
-47.0%
62,535
-15.1%
0.00%
Q3 2021$351,000
+258.2%
73,658
+191.1%
0.00%
Q2 2021$98,000
+6.5%
25,300
+28.5%
0.00%
Q1 2021$92,000
+104.4%
19,682
+35.8%
0.00%
Q4 2020$45,00014,4980.00%
Other shareholders
ANIXA BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Dorsey Wright & Associates 8,093$37,875,0000.44%
Wealth Alliance Advisory Group, LLC 20,100$94,0000.05%
Concorde Asset Management, LLC 13,000$61,0000.04%
B. Riley Wealth Management, Inc. 12,000$56,0000.01%
Accel Wealth Management 1,250$6,0000.01%
Spire Wealth Management 24,300$114,0000.00%
UBS Group AG 587,481$2,750,0000.00%
SEGALL BRYANT & HAMILL, LLC 17,400$82,0000.00%
Qube Research & Technologies Ltd 13,293$62,0000.00%
BANK OF AMERICA CORP /DE/ 8$00.00%
View complete list of ANIXA BIOSCIENCES INC shareholders